Canada markets closed

Kirin Holdings Co Ltd (KIR.SG)

Stuttgart - Stuttgart Delayed Price. Currency in EUR
Add to watchlist
13.100.00 (0.00%)
At close: 08:20AM CEST
Full screen
Loading interactive chart...
  • Reuters

    Kirin's electric spoon leaps from Ig Nobel infamy to the dinner table

    Japanese drinks giant Kirin Holdings will start selling an electrified spoon that researchers claim can promote healthier eating by enhancing salty tastes without extra sodium. Monday's product launch marks the first commercialisation of technology that last year won an Ig Nobel Prize, which honours unusual and whimsical research. Kirin will sell just 200 of its Electric Salt Spoons online for 19,800 yen ($127) this month and a limited run at a Japanese retailer in June, but is hoping for 1 million users globally within five years.

  • Business Wire

    Kirin Holdings will begin online sales of "Electric Salt Spoon", a spoon that uses electricity to enhance salty and umami taste*1, on May 20

    TOKYO, May 20, 2024--Kirin Holdings Company, Limited (Kirin) will launch as a new business in the Health Science domain (Health Science business) a limited offering of 200 units of Electric Salt Spoon, which enhances the salty and umami taste of low-sodium foods with the power of electricity, on Monday, May 20, 2024 at its official online store (https://electricsalt.shop.kirin.co.jp/). In addition, a limited number of units will be available at Hands Inc. stores beginning in June.This tableware-

  • Business Wire

    LC-Plasma-based Vaccine Research Selected for SCARDA Project

    TOKYO, May 08, 2024--Kirin Holdings Company, Limited (Kirin Holdings)(TOKYO:2503) and National Institute of Infectious Diseases (NIID) are jointly conducting studies to investigate the protective efficacy of L. lactis strain Plasma [postbiotic] (LC-Plasma) immunization against infectious diseases. We now announce that a proposal for our collaborative research has currently been accepted as a project for research and development into new modalities contributing to vaccine development by the Strat